Publication Name	World Journal of Psychiatry
Manuscript ID	76086
Country	China

Received	2022-03-01 02:23
Peer-Review Started	2022-03-01 02:24
To Make the First Decision
Return for Revision	2022-04-18 06:16
Revised	2022-04-19 09:46
Second Decision	2022-07-15 03:27
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-07-19 15:49
Articles in Press	2022-07-19 15:49
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-07-12 16:40
Typeset the Manuscript	2022-07-22 06:24
Publish the Manuscript Online	2022-08-18 07:25

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Behavioral Sciences
Manuscript Type	Letter to the Editor
Article Title	Underlying disease may increase mortality risk in users of atypical antipsychotics
Manuscript Source	Invited Manuscript
All Author List	Zhi-Peng Li, Yu-Shun You, Jun-Dong Wang and Lian-Ping He
ORCID	Author(s) ORCID Number Zhi-Peng Li http://orcid.org/0000-0002-0355-7889 Yu-Shun You http://orcid.org/0000-0002-6649-5283 Jun-Dong Wang http://orcid.org/0000-0003-3378-748X Lian-Ping He http://orcid.org/0000-0002-9627-5599
Funding Agency and Grant Number	Funding Agency Grant Number Curriculum Reform Project of Taizhou University in 2021 xkg2021087
Corresponding Author	Lian-Ping He, PhD, Teacher, School of Medicine, Taizhou University, No. 1139 Shifu Avenue, Jiaojiang District, Taizhou 318000, Zhejiang Province, China. lianpinghe@tzc.edu.cn
Key Words	Aripiprazole; Atypical antipsychotics; Dementia; Mortality rate; Psychiatry
Core Tip	Schizophrenia is a group of the most common types of mental illness. Type I schizophrenia involves mainly positive symptoms and type II schizophrenia involves mainly negative symptoms. The patients are indifferent and lack initiative. Clinically, atypical antipsychotics are often used as first-line drugs for first-episode schizophrenia. Although antipsychotics may increase mortality to some extent, observational studies suggest that atypical antipsychotics are associated with a lower risk of all-cause mortality when compared with conventional antipsychotics.
Publish Date	2022-08-18 07:25
Citation	Li ZP, You YS, Wang JD, He LP. Underlying disease may increase mortality risk in users of atypical antipsychotics. World J Psychiatry 2022; 12(8): 1112-1114
URL	https://www.wjgnet.com/2220-3206/full/v12/i8/1112.htm
DOI	https://dx.doi.org/10.5498/wjp.v12.i8.1112

Full Article (PDF)	WJP-12-1112.pdf
Full Article (Word)	WJP-12-1112.docx
Manuscript File	76086_Auto_Edited-LM.docx
Answering Reviewers	76086-Answering reviewers.pdf
Audio Core Tip	76086-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	76086-Conflict-of-interest statement.pdf
Copyright License Agreement	76086-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	76086-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	76086-Language certificate.pdf
Peer-review Report	76086-Peer-review(s).pdf
Scientific Misconduct Check	76086-Bing-Gao CC-2.png
Scientific Editor Work List	76086-Scientific editor work list.pdf
CrossCheck Report	76086-CrossCheck report.pdf